No menu items!

Brazilian Covid vaccine could be tested in humans in 2023

The Covid-19 vaccine developed by researchers at UFMG (Federal University of Minas Gerais) and Fiocruz (Oswaldo Cruz Foundation) could be tested in humans in early 2023, according to scientists involved in the project.

The immunizing SpiN-TEC has performed well in laboratory and animal studies.

However, the volunteer trial depends on meeting Anvisa's (National Health Authority) requirements.

Development of the vaccine began in March 2020 by UFMG's CT Vaccines in partnership with Fiocruz Minas and with support from the Ministry of Science, Technology, and Innovation.

At the end of July 2021, the researchers began applying for authorization . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content